StockSaints Logo 

Impax Laboratories Earnings Preview For Nov, 2013

Impax Laboratories Company Logo Image

Impax Laboratories Inc (IPXL)

Background: Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company engaged in the development, manufacture, and marketing of specialty prescription pharmaceutical products utilizing its own formulation expertise and drug delivery technologies. IMPAX Laboratories is focusing on two key areas, namely Generic Pharmaceutical Products and Branded Pharmaceutical Products. In the generic pharmaceuticals market, it focuses its efforts on controlled-release generic versions of selected brand-name pharmaceuticals covering a range of therapeutic areas. In the brand-name pharmaceuticals market, Impax is developing products for the treatment of central nervous system disorders. The company sells its products to large pharmaceutical wholesalers, warehousing chain drug stores, mass merchandisers, and mail-order pharmacies through strategic alliances and the company's global pharmaceuticals division.

Impax Laboratories Inc is forecast to report WEAK third-quarter earnings after the market closes on November 4, 2013.

The consensus estimate is currently losing seven cents a share, falling 55 cents (114.6%) from 48 cents during the same period last year. Analysts' estimates this quarter range from losing 21 cents, to a high of six cents per share.

The short interest is slightly elevated, albeit, not yet enough to make me want to worry about it. As long as it stays under 4%, I won't give it much thought. Short interest is 3.6%, and if it starts to trend higher I recommend monitoring for a possible exit.
 

 

(IPXL)

(MYL)

(TEVA)

Strong Buy

1

5

3

Moderate Buy

2

6

5

Hold

5

6

13

Moderate Sell Ratings

1

0

0

Strong Sell Ratings

1

1

2

Avg Analyst Price Target

$21.56

$38.82

$44.15

Revenue

$490.89 million

$7.04 billion

$20.06 billion

Est Low EPS

-0.21

0.77

1.21

Est High EPS

0.06

0.92

1.33

1 Year Stock Price Change

-3.38%

48.36%

-8.74%

Rate this article: 
Average: 5 (1 vote)
Stock Tickers: IPXL MYL TEVA Author Disclosure: n/a
Tickers: